Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
04 2020
Historique:
received: 19 07 2019
revised: 29 10 2019
accepted: 09 12 2019
pubmed: 20 2 2020
medline: 22 6 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

The aim of this study was to investigate prospectively the effect of sacubitril/valsartan in advanced heart failure (HF) patients in waiting list for heart transplantation (HT) and the effect on physical frailty (PF). We treated 37 consecutive patients with advanced HF with sacubitril/valsartan. Patients were followed up until HT, device implant, or last follow-up visit after 2 years of follow-up. At baseline, mean New York Heart Association (NYHA) class was 3.1 ± 0.4, with 64.9% in NYHA III and 35.1% NYHA IIIB. Left ventricular ejection fraction was 23.5 ± 5.8%, VO Our study showed a rapid improvement in PF in HT waiting list patients treated with sacubitril/valsartan. The improvement in all PF domains was paralleled by VO

Identifiants

pubmed: 32074411
doi: 10.1002/ehf2.12610
pmc: PMC7160499
doi:

Substances chimiques

Aminobutyrates 0
Biphenyl Compounds 0
Drug Combinations 0
Valsartan 80M03YXJ7I
sacubitril and valsartan sodium hydrate drug combination WB8FT61183

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-762

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

J Clin Med. 2019 Feb 20;8(2):
pubmed: 30791533
Circulation. 2019 Mar 12;139(11):1354-1365
pubmed: 30586756
Transplantation. 2016 Feb;100(2):429-36
pubmed: 26516676
ESC Heart Fail. 2020 Apr;7(2):757-762
pubmed: 32074411
Curr Heart Fail Rep. 2018 Dec;15(6):323-331
pubmed: 30178183
Int J Cardiol. 2017 Jun 1;236:283-289
pubmed: 28215466
JACC Heart Fail. 2019 Apr;7(4):291-302
pubmed: 30738977
Can J Cardiol. 2016 Sep;32(9):1157-65
pubmed: 27476983
Heart Fail Rev. 2013 Jul;18(4):529-51
pubmed: 23124913
Eur J Prev Cardiol. 2019 Jul;26(10):1115-1117
pubmed: 30722680
Eur J Clin Invest. 2005 Dec;35(12):723-30
pubmed: 16313247
Transplant Direct. 2017 May 30;3(7):e167
pubmed: 28706970
Curr Heart Fail Rep. 2014 Sep;11(3):266-73
pubmed: 24733407
JAMA Cardiol. 2018 Jun 1;3(6):498-505
pubmed: 29617523
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015

Auteurs

Francesco Cacciatore (F)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.
Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Cristiano Amarelli (C)

Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Ciro Maiello (C)

Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Irene Mattucci (I)

Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Gemma Salerno (G)

Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Marco Di Maio (M)

Department of Cardiology, Università degli Studi della Campania 'Luigi Vanvitelli', Monaldi Hospital, 80131, Naples, Italy.

Vittorio Palmieri (V)

Department of Cardiovascular Surgery and Transplant, Monaldi Hospital, Azienda dei Colli, 80131, Naples, Italy.

Francesco Curcio (F)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.

Flora Pirozzi (F)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.

Valentina Mercurio (V)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.

Giuditta Benincasa (G)

University Department of Advanced Medical and Surgical Sciences, Clinical Department of Internal and Specialty Medicine (DAI), Università degli Studi della Campania 'Luigi Vanvitelli', 80138, Naples, Italy.

Paolo Golino (P)

Department of Cardiology, Università degli Studi della Campania 'Luigi Vanvitelli', Monaldi Hospital, 80131, Naples, Italy.

Domenico Bonaduce (D)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.

Claudio Napoli (C)

University Department of Advanced Medical and Surgical Sciences, Clinical Department of Internal and Specialty Medicine (DAI), Università degli Studi della Campania 'Luigi Vanvitelli', 80138, Naples, Italy.

Pasquale Abete (P)

Department of Translational Medical Sciences, University of Naples 'Federico II', 80131, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH